Daniel Kolarich

Daniel Kolarich is Professor and ARC Future Fellow at Griffith University's School of Environment and Science, Department of Chemistry and Forensic Science. He leads the cancer glycomics initiative at the Australian Centre for Cancer Glycomics and the Advanced Mass Spectrometry Facility at the Institute for Glycomics. His academic background includes a PhD from the University of Natural Resources and Life Sciences Vienna, habilitation at Freie Universität Berlin, and postdoctoral positions at Macquarie University and Max Planck Institute.

Kolarich's research focuses on glycosylation in cancer biology, developing glycan-sequencing technologies for clinical applications. His work has pioneered sequencing from as few as 1000 cells, enabling comprehensive glycosylation mapping in ovarian, breast, prostate, and other cancers. Research interests include glycoproteomics, viral-host interactions, and receptor tyrosine kinase glycosylation.

His publications predominantly explore glycoproteomic informatics, cancer glycobiology, and HIV assembly mechanisms. Recent work reveals structural aspects of viral particle formation and glycan-mediated host-pathogen interactions.

Kolarich has supervised 13 doctoral students to completion and leads current projects on novel diagnostics and Pseudomonas aeruginosa treatment. Awards include an ARC Future Fellowship, Marie Curie Integration Grant, and Sanofi-Aventis Prize. He serves as Editor-in-Chief of the Glycoconjugate Journal.

His laboratory develops spatial transcriptomics and light sheet fluorescence microscopy techniques. International collaborations focus on translating glycomic discoveries into precision medicine applications for early cancer detection.